EMR Return on Equity (ROE) Analysis

Return on Equity (ROE) measures how much profit a company generates for each dollar of shareholders’ equity, so a 12.8% return means EMR earns $0.128 for every $1 of owner investment.

This sits just below the sector median of 13.6%, placing EMR at the 47th percentile among peers — essentially average. While the 8-quarter trend direction is not available, the year-over-year change is also not available; however, the quarter-over-quarter change shows a +4.1% improvement. The current ROE is slightly below the sector norm, but the recent quarterly gain suggests momentum that could narrow that gap. For an investor, this level and short-term uptrend implies moderate risk: no clear competitive advantage, but no sign of deterioration either. This metric supports the overall NEUTRAL verdict, as EMR’s profitability is neither a standout strength nor a notable weakness.

Frequently Asked Questions